Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm

Kuehn Law is soliciting shareholders of Travere Therapeutics to investigate potential breaches of fiduciary duties by the company's officers and directors. The firm is examining potential self-dealing and is offering investors a free consultation to discuss potential damages or corporate governance reforms.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.